Sargramostim Interactions
There are 186 drugs known to interact with sargramostim, along with 8 disease interactions. Of the total drug interactions, 3 are major, and 183 are moderate.
- View all 186 medications that may interact with sargramostim
- View sargramostim disease interactions (8)
Most frequently checked interactions
View interaction reports for sargramostim and the medicines listed below.
- Abelcet (amphotericin b lipid complex)
- Accutane (isotretinoin)
- Actemra (tocilizumab)
- Acthar (corticotropin)
- Activase (alteplase)
- Adasuve (loxapine)
- Advair Diskus (fluticasone / salmeterol)
- Aerolate III (theophylline)
- Alaway (ketotifen ophthalmic)
- Amphojel (aluminum hydroxide)
- AndroGel (testosterone)
- Anoro Ellipta (umeclidinium / vilanterol)
- Anzemet (dolasetron)
- Apresoline (hydralazine)
- Apriso (mesalamine)
- Aranelle (ethinyl estradiol / norethindrone)
- Aranesp (darbepoetin alfa)
- Arava (leflunomide)
- Aricept ODT (donepezil)
- Arnuity Ellipta (fluticasone)
- Asacol (mesalamine)
- Asper-Flex (trolamine salicylate topical)
- Ativan (lorazepam)
- Azilect (rasagiline)
- Bactrim (sulfamethoxazole / trimethoprim)
- Bactroban (mupirocin topical)
- Basaglar (insulin glargine)
- Belbuca (buprenorphine)
- Belviq (lorcaserin)
- Lotensin (benazepril)
Sargramostim disease interactions
There are 8 disease interactions with sargramostim which include:
- arrhythmia
- fluid retention
- hepatic dysfunction
- leukocytosis
- myeloid tumors
- prematurity
- renal dysfunction
- respiratory symptoms
Report options
QR code containing a link to this page
More about sargramostim
- sargramostim consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: colony stimulating factors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.